Teva Pharmaceutical Industries (TEVA) Return on Equity: 2017-2025
Historic Return on Equity for Teva Pharmaceutical Industries (TEVA) over the last 8 years, with Sep 2025 value amounting to 0.09%.
- Teva Pharmaceutical Industries' Return on Equity rose 49.00% to 0.09% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09%, marking a year-over-year increase of 49.00%. This contributed to the annual value of -0.29% for FY2024, which is 22.00% down from last year.
- According to the latest figures from Q3 2025, Teva Pharmaceutical Industries' Return on Equity is 0.09%, which was up 466.46% from -0.03% recorded in Q2 2025.
- In the past 5 years, Teva Pharmaceutical Industries' Return on Equity registered a high of 0.09% during Q3 2025, and its lowest value of -0.39% during Q3 2024.
- Its 3-year average for Return on Equity is -0.23%, with a median of -0.27% in 2024.
- In the last 5 years, Teva Pharmaceutical Industries' Return on Equity plummeted by 35bps in 2021 and then soared by 49bps in 2025.
- Teva Pharmaceutical Industries' Return on Equity (Quarterly) stood at 0.04% in 2021, then crashed by 32bps to -0.28% in 2022, then decreased by 9bps to -0.37% in 2023, then rose by 20bps to -0.17% in 2024, then soared by 49bps to 0.09% in 2025.
- Its last three reported values are 0.09% in Q3 2025, -0.03% for Q2 2025, and -0.23% during Q1 2025.